[2'-O-Me-G(iBu)-3'-CE-Phosphoramidite]](http://shop.hongene.com/cdn/shop/files/OP-140_df0a4a0a-08d8-4160-919b-16189c913b5a.jpg?v=1748589087&width=600)
[5'-O-DMTr-2'-OMe-G(iBu)](pCyEt)[2'-O-Me-G(iBu)-3'-CE-Phosphoramidite]
| Catalog No. | OP-140 |
| Purity | HPLC≥95.0% |
| Molecular Formula | C63H79N13O17P2 |
| Molecular Weight | 1352.35 |
| Storage Condition | -20℃ |
[5'-O-DMTr-2'-OMe-G(iBu)](pCyEt)[2'-O-Me-G(iBu)-3'-CE-Phosphoramidite]
[5'-O-DMTr-2'-OMe-G(iBu)](pCyEt)[2'-O-Me-G(iBu)-3'-CE-Phosphoramidite] - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Specifications
Specifications
-
Catalog No.OP-140
-
SMILESO=P(OCCC#N)(O[C@H]1[C@@H](OC)[C@H](N(C=N2)C3=C2C(NC(NC(C(C)C)=O)=N3)=O)O[C@@H]1COC(C4=CC=CC=C4)(C5=CC=C(OC)C=C5)C6=CC=C(OC)C=C6)OC[C@H]7O[C@@H](N(C=N8)C9=C8C(NC(NC(C(C)C)=O)=N9)=O)[C@H](OC)[C@@H]7OP(OCCC#N)N(C(C)C)C(C)C
-
Molecular FormulaC63H79N13O17P2
-
Molecular Weight1352.35
-
AppearanceWhite to off-white powder
-
PurityHPLC≥95.0%
-
Storage Condition-20℃
Documentation
Documentation
-
Catalog No.OP-140
-
SMILESO=P(OCCC#N)(O[C@H]1[C@@H](OC)[C@H](N(C=N2)C3=C2C(NC(NC(C(C)C)=O)=N3)=O)O[C@@H]1COC(C4=CC=CC=C4)(C5=CC=C(OC)C=C5)C6=CC=C(OC)C=C6)OC[C@H]7O[C@@H](N(C=N8)C9=C8C(NC(NC(C(C)C)=O)=N9)=O)[C@H](OC)[C@@H]7OP(OCCC#N)N(C(C)C)C(C)C
-
Molecular FormulaC63H79N13O17P2
-
Molecular Weight1352.35
-
AppearanceWhite to off-white powder
-
PurityHPLC≥95.0%
-
Storage Condition-20℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
